Are Survey-Based Estimates of the Burden of Drug Resistant TB Too Low? Insight from a Simulation Study
Open Access
- 4 June 2008
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 3 (6), e2363
- https://doi.org/10.1371/journal.pone.0002363
Abstract
The emergence of tuberculosis resistant to multiple first- and second-line antibiotics poses challenges to a global control strategy that relies on standard drug treatment regimens. Highly drug-resistant strains of Mycobacterium tuberculosis have been implicated in outbreaks and have been found throughout the world; a comprehensive understanding the magnitude of this threat requires an accurate assessment of the worldwide burden of resistance. Unfortunately, in many settings where resistance is emerging, laboratory capacity is limited and estimates of the burden of resistance are obtained by performing drug sensitivity testing on a sample of incident cases rather than through the use of routine surveillance. Using an individual-based dynamic tuberculosis model to simulate surveillance strategies for drug resistance, we found that current surveys may underestimate the total burden of resistant tuberculosis because cases of acquired resistance are undercounted and resistance among prevalent cases is not assessed. We explored how this bias is affected by the maturity of the epidemic and by the introduction of interventions that target the emergence and spread of resistant tuberculosis. Estimates of drug resistant tuberculosis based on samples of incident cases should be viewed as a lower bound of the total burden of resistance.This publication has 30 references indexed in Scilit:
- Challenges in Estimating the Total Burden of Drug-resistant TuberculosisAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Multidrug-resistant tuberculosisBMC Infectious Diseases, 2008
- Worldwide Emergence of Extensively Drug-resistant TuberculosisEmerging Infectious Diseases, 2007
- Exogenous re-infection and the dynamics of tuberculosis epidemics: local effects in a network model of transmissionJournal of The Royal Society Interface, 2006
- The Competitive Cost of Antibiotic Resistance in Mycobacterium tuberculosisScience, 2006
- Impact of Bacterial Genetics on the Transmission of Isoniazid-Resistant Mycobacterium tuberculosisPLoS Pathogens, 2006
- Genotypic and Phenotypic Heterogeneity amongMycobacterium tuberculosisIsolates from Pulmonary Tuberculosis PatientsJournal of Clinical Microbiology, 2004
- Multiple Mycobacterium tuberculosis Strains in Early Cultures from Patients in a High-Incidence Community SettingJournal of Clinical Microbiology, 2002
- Simultaneous Infection with Multiple Strains ofMycobacterium tuberculosisClinical Infectious Diseases, 2001
- Double infection with a Resistant and a Multidrug-Resistant Strain of Mycobacterium tuberculosisEmerging Infectious Diseases, 2000